floxuridine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Peripheral blood from six patients with Huntington's disease (HD) and six controls were cultured in three types of media known to produce fragile sites." | 1.27 | Absence of significant autosomal lesions in Huntington's disease. ( Beverstock, GC; Mol, A; Wienhofer, E, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beverstock, GC | 1 |
| Mol, A | 1 |
| Wienhofer, E | 1 |
1 other study available for floxuridine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Absence of significant autosomal lesions in Huntington's disease.
Topics: Adolescent; Adult; Aged; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fr | 1985 |